Rickvan 't Hullenaar


Amsterdam + 31.20.305.4223

Rick van 't Hullenaar assists multinational companies in preventing and managing regulatory, reputational, and compliance risks and in responding to incidents of corporate irregularities and compliance failures. He has in-depth experience in addressing matters relating to international trade, economic sanctions, and export controls.

Rick conducts cross-border internal investigations regarding a variety of issues, including corruption, bribery, fraud, economic sanctions, export controls, and other regulatory or reputational issues. His experience includes investigations in Europe, Asia, Africa, South America, and the Middle East. With his substantial knowledge in international trade and economic sanctions, he is also active in Brussels, which is an important regulatory hub in the EU.

In addition, Rick assists companies in assessing their compliance risks, including in a transactional context. He advises clients on compliance with international trade and other regulatory regimes, including economic sanctions, anti-money laundering regulations, and foreign direct investment controls.

Rick is a visiting lecturer at Leiden University and a frequent speaker at conferences on subjects spanning his areas of practice. Prior to joining Jones Day in 2019, he worked in the Amsterdam and London offices of an international law firm.


  • Eurobio Scientific acquires GenDxJones Day advised Eurobio Scientific SA in the acquisition and financing of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for €135 million (net of adjusted cash).
  • Avient acquires DSM Protective Materials businessJones Day advised Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable material solutions, in the $1.485 billion acquisition and financing of Koninklijke DSM N.V.’s protective materials business, a leading specialty engineered materials business built around the invention of Dyneema®, the world’s strongest fiber.
  • MassMutual provides $130 million revolving credit facility to SPV, managed by leading global investment firmJones Day represented Massachusetts Mutual Life Insurance Company, as lead lender, in connection with a $130 million revolving credit facility provided to a special purpose vehicle under the management of a leading global investment firm.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Koch Equity Development acquires Transaction Network ServicesJones Day advised Koch Equity Development LLC, the acquisition and investment subsidiary of Koch Industries, Inc., in the acquisition of Transaction Network Services, Inc. (TNS) from affiliates of Siris Capital Group, LLC and TNS' other minority equity holders.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.